E. Lanoy

Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor‐sparing therapy in patients with lipoatrophy: results from the 96‐week randomized ANRS 108 NoNuke Trial

V. Calvez, C. Katlama, W. Rozenbaum, 2008, HIV medicine.

How does loss to follow‐up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates *

D. Costagliola, C. Lewden, G. Chêne, 2009, HIV medicine.

Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).

D. Costagliola, C. Roux, M. Valantin, 2012, AIDS research and human retroviruses.

Survival after neuroAIDS

D. Costagliola, C. Dhiver, I. Poizot-Martin, 2011, Neurology.

Causes of the first AIDS‐defining illness and subsequent survival before and after the advent of combined antiretroviral therapy *

D Costagliola, E. Lanoy, D. Costagliola, 2008, HIV Medicine.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.